Abstract
A recent study has demonstrated that adiponectin inhibited hypertrophic signaling in the myocardium of mice, implying that a decrease in the blood adiponectin level could cause cardiac muscle hypertrophy. We hypothesized that a relationship might exist between the serum adiponectin level and electrocardiographically diagnosed left ventricular hypertrophy (ECG-LVH), and we examined this hypothesis by epidemiological study of 2839 Japanese male workers who were not taking medications for hypertension. ECG-LVH was defined as meeting Sokolow-Lyon voltage criteria and/or Cornell voltage-duration product. The subjects were categorized by tertiles of serum adiponectin level, and a multivariate logistic regression analysis was conducted relating left ventricular hypertrophy to adiponectin tertiles adjusting for potential confounding factors. Prevalence of ECG-LVH in the studied sample was 16.7%. Adiponectin ranged from 1.0 to 5.0 μg/mL in the lowest category and from 7.4 to 30.6 μg/mL in the highest. Compared with subjects in the highest adiponectin category, those in the lowest one had a significantly higher prevalence of ECG-LVH independent of age, body mass index, and systolic blood pressure with an odds ratio of 1.50 and a 95% CI of 1.16 to 1.94. Further adjustment for high-density lipoprotein cholesterol, triglyceride, and insulin resistance did not change the association (odds ratio: 1.68; 95% CI: 1.28 to 2.21; P<0.001). Similar results were obtained when different criteria for ECG-LVH were used or when subjects were stratified by blood pressure or body mass index. Adiponectin concentration was inversely and independently associated with ECG-LVH in Japanese men.
| Original language | English |
|---|---|
| Pages (from-to) | 1448-1454 |
| Number of pages | 7 |
| Journal | Hypertension |
| Volume | 49 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 01-06-2007 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Internal Medicine
Cite this
}
Adiponectin level and left ventricular hypertrophy in Japanese men. / Mitsuhashi, Hirotsugu; Yatsuya, Hiroshi; Tamakoshi, Koji; Matsushita, Kunihiro; Otsuka, Rei; Wada, Keiko; Sugiura, Kaichiro; Takefuji, Seiko; Hotta, Yo; Kondo, Takahisa; Murohara, Toyoaki; Toyoshima, Hideaki.
In: Hypertension, Vol. 49, No. 6, 01.06.2007, p. 1448-1454.Research output: Contribution to journal › Article
TY - JOUR
T1 - Adiponectin level and left ventricular hypertrophy in Japanese men
AU - Mitsuhashi, Hirotsugu
AU - Yatsuya, Hiroshi
AU - Tamakoshi, Koji
AU - Matsushita, Kunihiro
AU - Otsuka, Rei
AU - Wada, Keiko
AU - Sugiura, Kaichiro
AU - Takefuji, Seiko
AU - Hotta, Yo
AU - Kondo, Takahisa
AU - Murohara, Toyoaki
AU - Toyoshima, Hideaki
PY - 2007/6/1
Y1 - 2007/6/1
N2 - A recent study has demonstrated that adiponectin inhibited hypertrophic signaling in the myocardium of mice, implying that a decrease in the blood adiponectin level could cause cardiac muscle hypertrophy. We hypothesized that a relationship might exist between the serum adiponectin level and electrocardiographically diagnosed left ventricular hypertrophy (ECG-LVH), and we examined this hypothesis by epidemiological study of 2839 Japanese male workers who were not taking medications for hypertension. ECG-LVH was defined as meeting Sokolow-Lyon voltage criteria and/or Cornell voltage-duration product. The subjects were categorized by tertiles of serum adiponectin level, and a multivariate logistic regression analysis was conducted relating left ventricular hypertrophy to adiponectin tertiles adjusting for potential confounding factors. Prevalence of ECG-LVH in the studied sample was 16.7%. Adiponectin ranged from 1.0 to 5.0 μg/mL in the lowest category and from 7.4 to 30.6 μg/mL in the highest. Compared with subjects in the highest adiponectin category, those in the lowest one had a significantly higher prevalence of ECG-LVH independent of age, body mass index, and systolic blood pressure with an odds ratio of 1.50 and a 95% CI of 1.16 to 1.94. Further adjustment for high-density lipoprotein cholesterol, triglyceride, and insulin resistance did not change the association (odds ratio: 1.68; 95% CI: 1.28 to 2.21; P<0.001). Similar results were obtained when different criteria for ECG-LVH were used or when subjects were stratified by blood pressure or body mass index. Adiponectin concentration was inversely and independently associated with ECG-LVH in Japanese men.
AB - A recent study has demonstrated that adiponectin inhibited hypertrophic signaling in the myocardium of mice, implying that a decrease in the blood adiponectin level could cause cardiac muscle hypertrophy. We hypothesized that a relationship might exist between the serum adiponectin level and electrocardiographically diagnosed left ventricular hypertrophy (ECG-LVH), and we examined this hypothesis by epidemiological study of 2839 Japanese male workers who were not taking medications for hypertension. ECG-LVH was defined as meeting Sokolow-Lyon voltage criteria and/or Cornell voltage-duration product. The subjects were categorized by tertiles of serum adiponectin level, and a multivariate logistic regression analysis was conducted relating left ventricular hypertrophy to adiponectin tertiles adjusting for potential confounding factors. Prevalence of ECG-LVH in the studied sample was 16.7%. Adiponectin ranged from 1.0 to 5.0 μg/mL in the lowest category and from 7.4 to 30.6 μg/mL in the highest. Compared with subjects in the highest adiponectin category, those in the lowest one had a significantly higher prevalence of ECG-LVH independent of age, body mass index, and systolic blood pressure with an odds ratio of 1.50 and a 95% CI of 1.16 to 1.94. Further adjustment for high-density lipoprotein cholesterol, triglyceride, and insulin resistance did not change the association (odds ratio: 1.68; 95% CI: 1.28 to 2.21; P<0.001). Similar results were obtained when different criteria for ECG-LVH were used or when subjects were stratified by blood pressure or body mass index. Adiponectin concentration was inversely and independently associated with ECG-LVH in Japanese men.
UR - http://www.scopus.com/inward/record.url?scp=34249287973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249287973&partnerID=8YFLogxK
U2 - 10.1161/HYPERTENSIONAHA.106.079509
DO - 10.1161/HYPERTENSIONAHA.106.079509
M3 - Article
VL - 49
SP - 1448
EP - 1454
JO - Hypertension
JF - Hypertension
SN - 0194-911X
IS - 6
ER -